A1LN34
Alnylam Pharmaceuticals, Inc.
BR Healthcare Biotechnology
- Latest week
- 29 May 2026
- Close
- 77.120003
- Fair value
- 72.083846
- Expectation
- Negative 38.60%
Chart Summary
Key Points
- Week Ending
- 29 May 2026
- Latest Close
- 77.12
- 12-Week Change
- -5.86%
- Trend Signal
- Inactive
- Expectation
- Negative 38.60%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -31.12
- Market Dynamics
- -0.34
Over the latest 12 completed weeks ending 2026-05-29, A1LN34 fell 5.86%, moving from 81.92 to 77.12. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -31.12 and has improved across the 12-week window. Market Dynamics is -0.34 on the latest week. Expectation is negative at 38.60%.